Literature DB >> 26192776

The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.

Philip Kiely1, Mike Catton2, Dianne Brown1, Doris Chibo2, Theo Karapanagiotidis2, Denis Spelman3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26192776      PMCID： PMC4624547          DOI： 10.2450/2015.0034-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  9 in total

1.  Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

Authors:  Clive R Seed; Angelo R Margaritis; Wayne V Bolton; Philip Kiely; Susan Parker; Lisa Piscitelli
Journal:  Transfusion       Date:  2003-02       Impact factor: 3.157

2.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

3.  International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.

Authors:  W K Roth; M P Busch; A Schuller; S Ismay; A Cheng; C R Seed; C Jungbauer; P M Minsk; D Sondag-Thull; S Wendel; J E Levi; M Fearon; G Delage; Y Xie; I Jukic; P Turek; H Ullum; V Tefanova; M Tilk; R Reimal; J Castren; M Naukkarinen; A Assal; C Jork; M K Hourfar; P Michel; R Offergeld; L Pichl; M Schmidt; V Schottstedt; E Seifried; F Wagner; M Weber-Schehl; C Politis; C K Lin; W C Tsoi; J O'Riordan; A Gottreich; E Shinar; V Yahalom; C Velati; M Satake; N Sanad; I Sisene; A H Bon; M Koppelmann; P Flanagan; O Flesland; E Brojer; M Lętowska; F Nascimento; E Zhiburt; S S Chua; D Teo; S Levicnik Stezinar; M Vermeulen; R Reddy; Q Park; E Castro; A Eiras; I Gonzales Fraile; P Torres; B Ekermo; C Niederhauser; H Chen; S Oota; L J Brant; R Eglin; L Jarvis; L Mohabir; J Brodsky; G Foster; C Jennings; E Notari; S Stramer; D Kessler; C Hillyer; H Kamel; L Katz; C Taylor; S Panzer; H W Reesink
Journal:  Vox Sang       Date:  2011-09-21       Impact factor: 2.144

4.  A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.

Authors:  Michael P Busch; Simone A Glynn; Susan L Stramer; D Michael Strong; Sally Caglioti; David J Wright; Brandee Pappalardo; Steven H Kleinman
Journal:  Transfusion       Date:  2005-02       Impact factor: 3.157

5.  Analysis of sample-to-cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing.

Authors:  Philip Kiely; Kyall Walker; Susan Parker; Anthea Cheng
Journal:  Transfusion       Date:  2010-01-22       Impact factor: 3.157

Review 6.  Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.

Authors:  Steven G Deeks; Bruce D Walker
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

7.  Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.

Authors:  J B Jackson; M R Hanson; G M Johnson; T G Spahlinger; H F Polesky; R J Bowman
Journal:  Transfusion       Date:  1995-02       Impact factor: 3.157

8.  Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.

Authors:  M P Busch; L L Lee; G A Satten; D R Henrard; H Farzadegan; K E Nelson; S Read; R Y Dodd; L R Petersen
Journal:  Transfusion       Date:  1995-02       Impact factor: 3.157

9.  Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.

Authors:  M P Busch; S H Kleinman; A E Williams; J W Smith; H E Ownby; M E Laycock; L L Lee; C P Pau; G B Schreiber
Journal:  Transfusion       Date:  1996-01       Impact factor: 3.157
  9 in total
  1 in total

1.  Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.

Authors:  Karina Oganezova; Elvin J Fontana-Martinez; Jon A Gothing; Alisha Pandit; Esther Kwara; Katherine Yanosick; Joan Dragavon; Erin A Goecker; Janine Maenza; Nicole Espy; Frank Tomaka; Ludo Lavreys; Mary Allen; Patricia D'Souza; John Hural; Robert W Coombs; Raphael Dolin; Michael S Seaman; Stephen R Walsh; Lindsey R Baden
Journal:  Open Forum Infect Dis       Date:  2020-12-15       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.